<p><b>A:</b> 50% neutralizing titers (in plasma dilution) of autologous CAP256 plasma from week 145 p.i. against free virus (black) and cell-cell transmission (red) of CAP256 virus strains is depicted. Data are means of 2 to 3 independent experiments. Inhibition of <i>SU-like VRC26 sensitive viruses</i> and <i>SU-like VRC26 early escape</i> viruses in free virus and cell-cell transmission were compared using the Mann-Whitney test. P values are indicated in black and red respectively. <b>B:</b> The change in neutralization activity for cell-cell compared to free virus transmission is shown as the ratio of NT50<sup>free-virus</sup>/NT50<sup>cell-cell</sup> (Fold change Neutralizing titer). Zero denotes equal activity in both transmission path...
<p>Mean IC<sub>50</sub> values with standard deviation of A: study subject CMNYU133. B: study subjec...
<p>Plasma samples are from chronically infected individuals not currently on treatment. Titers are e...
<p>Percent change in the plasma IC50 titers of kifunensine-treated (red) and swainsonine-treated (gr...
<p><b>A: Comparable potency of bnAbs CAP256-VRC26.08 and CAP256-VRC26.09 during free virus and cell-...
<p>A: Mean IC<sub>50</sub> values with standard deviation of initial and superinfecting virus varian...
<p>A: Mean IC<sub>50</sub> values with standard deviation of initial and superinfecting virus varian...
<p>A: Mean IC<sub>50</sub> values with standard deviation of initial and superinfecting virus varian...
<p>(A) Bar graph showing percentage neutralization breadth of CAP248 plasma at ID<sub>50</sub> titer...
<p><b>A:</b> Schematic of free virus infection of A3.01-CCR5 target cells to measure total and pre-a...
<p><b>A</b>) Longitudinal neutralization of the autologous CAP257 virus (black) and 37 heterologous ...
<p>Interdependencies of inhibitory activity (IC<sub>50</sub>) against free and cell-cell transmitted...
<p>The proportion of AE-Env-recombinant viruses in which replication was inhibited by a plasma sampl...
The virus neutralization data from Fig 2 were plotted as a function of the source of virus (plasma v...
<p>Paired pseudotyped viruses from CSF and blood were exposed to serial dilutions of bNAbs, sCD4 or ...
<p>Shown is % neutralization with ≥80% reduction in virus titer in bold. Plasma were tested at a 1 i...
<p>Mean IC<sub>50</sub> values with standard deviation of A: study subject CMNYU133. B: study subjec...
<p>Plasma samples are from chronically infected individuals not currently on treatment. Titers are e...
<p>Percent change in the plasma IC50 titers of kifunensine-treated (red) and swainsonine-treated (gr...
<p><b>A: Comparable potency of bnAbs CAP256-VRC26.08 and CAP256-VRC26.09 during free virus and cell-...
<p>A: Mean IC<sub>50</sub> values with standard deviation of initial and superinfecting virus varian...
<p>A: Mean IC<sub>50</sub> values with standard deviation of initial and superinfecting virus varian...
<p>A: Mean IC<sub>50</sub> values with standard deviation of initial and superinfecting virus varian...
<p>(A) Bar graph showing percentage neutralization breadth of CAP248 plasma at ID<sub>50</sub> titer...
<p><b>A:</b> Schematic of free virus infection of A3.01-CCR5 target cells to measure total and pre-a...
<p><b>A</b>) Longitudinal neutralization of the autologous CAP257 virus (black) and 37 heterologous ...
<p>Interdependencies of inhibitory activity (IC<sub>50</sub>) against free and cell-cell transmitted...
<p>The proportion of AE-Env-recombinant viruses in which replication was inhibited by a plasma sampl...
The virus neutralization data from Fig 2 were plotted as a function of the source of virus (plasma v...
<p>Paired pseudotyped viruses from CSF and blood were exposed to serial dilutions of bNAbs, sCD4 or ...
<p>Shown is % neutralization with ≥80% reduction in virus titer in bold. Plasma were tested at a 1 i...
<p>Mean IC<sub>50</sub> values with standard deviation of A: study subject CMNYU133. B: study subjec...
<p>Plasma samples are from chronically infected individuals not currently on treatment. Titers are e...
<p>Percent change in the plasma IC50 titers of kifunensine-treated (red) and swainsonine-treated (gr...